|
Alex M. Chen
Co-founder, CEO
Pursued Ph.D. in Chemistry from Rutgers University 8 years at Merck in R&D and manufacturing division Supported physical characterization, API phase selection and evaluation of more than 50 compounds in all stages of development Expert in solid-state characterization, polymorphism, co-crystal screening, chiral resolution, and nanoparticle engineering
|
Yanfeng Zhang
Co-founder, CSO
Pursued Ph.D. in Chemical Engineering from Princeton University 5 years at Merck supporting more than 80 development projects in close collaboration with scientists in multiple disciplines Expertise in solid-state research, salt/polymorph screen and selection, amorphous solid dispersion, thermodynamics and kinetics modeling
|
|
Robert Wenslow
Co-founder, VP B.D.–US & EU
Ph.D. in Chemistry from Pennsylvania State University 14 years at Merck in drug R&D, manufacturing and management Expertise in solid-state NMR, maintaining direct responsibilities of solid-state NMR facility at Merck Established first analytical research group in Ireland for Merck
|
Rositza Petrova
Executive Director, Head of NJ Site
Ph.D. in Materials Science, Georgetown University (Studied chiral separation and crystallization in gels under Professor Jennifer Swift, Ph.D.) Expert in API solid form screening/discovery, crystalline form selection, polymorphism and chiral separations by crystallization 15 years working experience in Merck with various leadership position including Leader of API Development Support Group - Center for Materials Science and Engineering in Merck Manufacturing Division, and Analytical Project Leader - Merck Animal Health
|
